(Q43870689)

27 November 2017

title

Toxic interaction between risperidone and clozapine: a case report (English)

1 reference

27 November 2017

1 reference

Vassilis P Kontaxakis

1

1 reference

27 November 2017

Beata J Havaki-Kontaxaki

2

1 reference

27 November 2017

Sophia S Stamouli

3

1 reference

27 November 2017

George N Christodoulou

4

1 reference

27 November 2017

publication date

1 February 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

27 November 2017

published in

1 reference

27 November 2017

volume

26

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

407-409

1 reference

Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Spectrum concept of neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Catatonia and the neuroleptics: psychobiologic significance of remote and recent findings

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Neuroleptic malignant syndrome after antipsychotic drug administration during benzodiazepine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

The spectrum concept of neuroleptic toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Neuroleptic malignant syndrome and catatonia: one entity or two?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Catatonic signs in neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Cross-tapering clozapine and risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Recurrence pattern of serum creatine phosphokinase levels in repeated acute psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Risperidone and clozapine combination for the treatment of refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Drug metabolism and atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Neuroleptic toxicity syndromes: a clinical spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

Pharmacokinetic interaction between risperidone and clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900257-3

7 January 2021

10.1016/S0278-5846(01)00257-3

Identifiers

DOI

1 reference

27 November 2017

1 reference